Shih I M, Kurman R J
Department of Pathology, Johns Hopkins Hospital, Baltimore, MD 21287-6917, USA.
Int J Gynecol Pathol. 1999 Apr;18(2):144-50. doi: 10.1097/00004347-199904000-00008.
The immunohistochemical distribution of inhibin-alpha in formalin-fixed, paraffin-embedded tissues was evaluated in placentas (2 to 40 weeks of gestation), implantation sites, and a variety of trophoblastic lesions. In the first trimester placenta, inhibin-alpha was strongly and diffusely expressed in syncytiotrophoblast. Implantation site intermediate trophoblast in normal and exaggerated placental sites was either negative or only weakly and focally positive for inhibin-alpha. With increasing gestational age, the staining intensity and distribution of inhibin-alpha decreased in syncytiotrophoblast but increased in the implantation site intermediate trophoblast. Chorionic-type intermediate trophoblast, present in the chorion laeve of the term placenta, was weakly but diffusely positive for inhibin-alpha. Cytotrophoblast remained negative for inhibin-alpha throughout gestation. In trophoblastic lesions, inhibin-alpha immunoreactivity was detected in all 17 hydatidiform moles (7 complete and 10 partial), 32 placental site nodules, 23 placental site trophoblastic tumors, 15 epithelioid trophoblastic tumors, and 16 choriocarcinomas. Inhibin-alpha immunoreactivity was confined to the syncytiotrophoblast in hydatidiform moles and choriocarcinoma. As with the normal placenta, inhibin-alpha was not detected in cytotrophoblast. To evaluate the utility of inhibin-alpha in the differential diagnosis of gestational trophoblastic lesions, we tested 32 squamous cell carcinoma of the cervix, 11 low-grade endometrial stromal sarcomas, 12 endometrial (7 well differentiated and 5 moderately differentiated) carcinomas, 7 epithelioid leiomyomas, and 10 leiomyosarcomas for the expression of inhibin-alpha. None of these lesions was positive. These data indicate that inhibin-alpha is expressed by all populations of trophoblast except cytotrophoblast and in all gestational trophoblastic lesions. Accordingly, immunohistochemical detection of inhibin-alpha is useful in the differential diagnosis of gestational trophoblastic lesions.
在福尔马林固定、石蜡包埋的组织中,评估抑制素α在胎盘(妊娠2至40周)、着床部位以及各种滋养层病变中的免疫组化分布。在孕早期胎盘中,抑制素α在合体滋养层中强烈且弥漫性表达。正常和过度增生胎盘部位的着床部位中间滋养层对抑制素α呈阴性或仅弱阳性且局灶性阳性。随着孕周增加,合体滋养层中抑制素α的染色强度和分布降低,但着床部位中间滋养层中增加。足月胎盘胎膜中的绒毛膜型中间滋养层对抑制素α呈弱阳性但弥漫性阳性。整个妊娠期细胞滋养层对抑制素α均呈阴性。在滋养层病变中,在所有17例葡萄胎(7例完全性和10例部分性)、32例胎盘部位结节、23例胎盘部位滋养层肿瘤、15例上皮样滋养层肿瘤和16例绒毛膜癌中均检测到抑制素α免疫反应性。葡萄胎和绒毛膜癌中抑制素α免疫反应性局限于合体滋养层。与正常胎盘一样,细胞滋养层中未检测到抑制素α。为了评估抑制素α在妊娠滋养层病变鉴别诊断中的效用,我们检测了32例宫颈鳞状细胞癌、11例低级别子宫内膜间质肉瘤、12例子宫内膜癌(7例高分化和5例中分化)、7例上皮样平滑肌瘤和10例平滑肌肉瘤中抑制素α的表达。这些病变均无阳性表达。这些数据表明,除细胞滋养层外,所有滋养层细胞群均表达抑制素α,且在所有妊娠滋养层病变中均有表达。因此,抑制素α的免疫组化检测在妊娠滋养层病变的鉴别诊断中有用途。